73 reports

  • Gastrointestinal Drugs Market Competitive Landscape
  • Gastrointestinal Drugs Market Forecast Growth

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors,...

  • Gastrointestinal Drug
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Gastrointestinal Drugs Global Market Report 2018 ##.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size

The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters.

  • Gastrointestinal Drug
  • OTC
  • World

Segments Covered ##) Global Gastrointestinal Drugs market a.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 07. Epidemiology of Gastrointestinal Disorders
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET BY THERAPEUTIC CLASS OF DRUG

About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal...

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.
  • Zantac
  • RECENT DEVELOPMENTS

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Market definition
  • MARKET ECOSYSTEM

You can easily book an appointment with one online.

  • Gastrointestinal Drug
  • World
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson

Our Gastrointestinal Portfolio.

  • Gastrointestinal Drug
  • World
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.
  • FAMOTIDINE, LANSOPRAZOLE AND TRANEXAMIC ACID ALONE OR IN COMBINATION HAVE THE HIGHEST NUMBER OF GASTROINTESTINAL BLEEDING (GASTROINTESTINAL HEMORRHAGE) ONGOING CLINICAL TRIALS.

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage)...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • OTC
  • APAC
  • World
  • Forecast
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials...

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Proportion of Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Clinical Trials by E7 Countries: Proportion of Diarrhea to Gastrointestinal Clinical Trials

Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Furiex Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Regional Sales of Gluten-Free Food 2012/2017/2022
  • Digestive Remedies Sales by Region: 2012/2017/2022

Japan and South Korea saw declines in sales over the same time period, with CAGRs of -##% and - ##%, respectively, while India only saw an increase of ##% over that time.

  • Gastrointestinal Drug
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • ESOPHAGEAL DISEASES THERAPEUTICS, GLOBAL, TERMINATED CLINICAL TRIALS, 2015*
  • ESOPHAGEAL DISEASES THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • ESOPHAGITIS THERAPEUTICS, GLOBAL, TERMINATED CLINICAL TRIALS, 2015*
  • ESOPHAGITIS THERAPEUTICS CLINICAL TRIALS MARKET, GLOBAL, CLINICAL TRIALS BY TAKEDA PHARMACEUTICAL COMPANY LIMITED,

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*

Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical...

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Salix Pharmaceuticals, Ltd.

The largest deal was the $##, ##m research, development, collaboration, and license agreement in January 2017 between Allergan and Assembly Biosciences for the worldwide rights to Assembly’s microbiome gastrointestinal development programs.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pharmaceutical
  • World

Drivers and their Impact Hospitals Low Low ## ## ## ## ## High High Impact on Key Customer Category Driver Low Pharmacies High ## ## ## ## ## Increase in Patient Population Improved Diagnosis Patient Assistance Programs ## ## ## ## ## Low Low ## ## ## ## ## High High ## ## ## ##

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

(Inactive) ## ## ## ## ## ## UCB S. A. ## ## ## ## ## ## Ocera Therapeutics, Inc. ## ## ## ## ## ## Debiopharm Group ## ## ## ## ## ## Advanced Clinical, LLC ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## Charles River Laboratories Intern

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

By Clinical Trial Stages: The report provides Gastrointestinal Disorders pipeline molecules by clinical trial stages including both early and late stage development - phase ## clinical trials, phase ## clinical trials, phase ## clinical trials, preclinical research, and discovery stag

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World

PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO GASTROINTESTINAL CLINICAL TRIALS, E## COUNTRIES (%), 2018* PROPORTION OF NONEROSIVE REFLUX DISEASE (NERD) TO

  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • PROPORTION OF INFECTIOUS DIARRHEA TO GASTROINTESTINAL CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

Infectious Diarrhea Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Infectious Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Infectious...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pathology
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## Epworth HealthCare Dianthus Medical Limited (Inactive) ## ## ## ## ## ## ## ## Cook Medical Inc Source: GlobalData' s Pharma Intelligence Center

  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Takeda Pharmaceutical Company Limited

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Merck & Co., Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • World
  • Product Initiative
  • AstraZeneca PLC